Vivos Inc (RDGL)

[SheikhPenny]

With the company keeping up to date with filings and changes in beneficial ownership we believe the CEO is preparing to for successful years with ADMD (Advanced Medical Isotope Corporation). On Friday (December 19, 2014) the company released much information to be transparent. Additionally, there was a press release which stated that Advanced Medical Isotope Corporation was awarded the LSDF Grant which is a PROOF OF CONCEPT GRANT. This shows that ADMD has indeed successfully proved the beneficial function of “Optimized Injectable Radiogels for High-dose Therapy of Non-resectable Solid Tumors”. Please see below for more information on how this therapy has usage for the treatment of cancer by targeting tumours.

Reliable sources estimate that annual sales of brachytherapy products exceed $1 billion, about half of which are in the United States. The size of the U.S. brachytherapy market for prostate cancer brachytherapy is somewhere between $90 million and $130 million per year. The market for liver and breast cancer combined is comparable.